Merck plans $3B cost cuts as Keytruda faces patent cliff Merck plans $3B cost cuts as Keytruda faces patent cliff Post Contentmrk, bmyRead More You might also be interested in reading First cross-chain governance proposal passes on Aave. July 29, 2025 In Mainstream ← Previous post Next post →